ČÁST Č. 1 – APIDRA
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 17689727 | 10. 01. 2022 | sanofi-aventis, s.r.o. | 7 163 200,00 | 6 512 000,00 | 7 163 200,00 | 6 512 000,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 740_01_Písemná zpráva.pdf | Písemná zpráva zadavatele | 17. 01. 2022 14:24 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| sanofi-aventis, s.r.o. | Praha | 6 511 680,00 | CZK | |||
| Alliance Healthcare s. r. o. | Praha | 6 548 192,00 | CZK | |||
| PHARMOS, a.s. | Ostrava | 6 531 168,00 | CZK | |||
| PHOENIX lékárenský velkoobchod, s.r.o. | Praha | 6 589 744,00 | CZK |
Price Actually Paid in Each Year of Performance
| 17689727 | 2023 | 1 566 873,00 | 1 424 430,00 |
| 17689727 | 2022 | 1 494 604,98 | 1 358 731,80 |